ENA-001 for Post Operative Respiratory Depression (PORD)

Summary

This study is a Phase II, randomized, placebo-controlled, double-blind trial in 200 subjects having general anesthesia for major elective surgery with postoperative pain management to evaluate the efficacy, safety and tolerability of ENA-001 as a therapy to prevent post operative respiratory depression.

Timeline

Start

2026-12-15

Primary completion

2027-06-15

Completion

2027-07-15

Drugs

Indications